ProCE Banner Activity

CME

Updates on the Management of Motor Signs and Symptoms of Parkinson Disease

Text Module
Choose your approach and get immediate feedback in these patient cases.

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: April 07, 2020

Expiration: April 06, 2021

No longer available for credit.

Share

Faculty

Stuart Isaacson

Stuart Isaacson, MD

Clinical Associate Professor of Neurology
FIU Herbert Wertheim College of Medicine
Miami, Florida
Director
Parkinsons Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida

Rajesh Pahwa

Rajesh Pahwa, MD

Chief, Parkinson and Movement Disorder Division
Director, Parkinson Foundation Center of Excellence
University of Kansas Medical Center
Kansas City, Kansas

Supporters

This activity is supported by an educational grant from

Acorda

Sunovion

Target Audience

This program is primarily intended for neurologists, geriatricians, primary care physicians, internal medicine physicians, nurse practitioners, physician assistants, and other healthcare providers who care for patients with Parkinson disease.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Review the efficacy and safety of agents for the management of early motor symptoms of PD
  • Outline pharmacologic options for managing motor fluctuations in PD
  • Describe factors that should be considered when using an on-demand management plan for late motor symptoms

Faculty Disclosure

Primary Author

Stuart Isaacson, MD

Clinical Associate Professor of Neurology
FIU Herbert Wertheim College of Medicine
Miami, Florida
Director
Parkinsons Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida

Stuart Isaacson, MD, has disclosed that he received: Consulting fees from AbbVie, Acadia, Acorda, Adamas, Addex, Allergan, Amarantus, Auspex, Axovant, Biotie, Britannia, Cynapsus, GE Healthcare, Impax, Ipsen, Kyowa, Lundbeck, Medtronics, National Parkinson Foundation, Neurocrine, Neuroderm, Orexa, Pfizer, Roche, Sunovion, Teva, UCB, US World Meds, Xenoport, Zambon; Speaker honoraria from AbbVie, Acadia, Allergan, American Parkinson Disease Association, Britannia, Cynapsus, GE Healthcare, Impax, Ipsen, Lundbeck, Neurocrine, National Parkinson Foundation, Teva, UCB, US World Meds, Xenoport, Zambon; and Grant/research support from AbbVie, Acadia, Acorda, Adamas, Addex, Allergan, Amarantus, Auspex, Avid, Axovant, AZTherapies, Biogen, Biotie, Cynapsus, Eisai, Eli Lilly, Enterin, GE Healthcare, Impax, Intec Pharma, Ipsen, Kyowa, Lundbeck, Merz, Michael J. Fox Foundation, Neurocrine, Neuroderm, National Institute of Neurological Disorders and Stroke/National Institutes of Health, Orexa, Parkinson Study Group, Pfizer, Pharma2B, Prothena, Roche, Sanofi, Shire, Sunovion, Teva, UCB, US World Meds, Xenoport

Rajesh Pahwa, MD

Chief, Parkinson and Movement Disorder Division
Director, Parkinson Foundation Center of Excellence
University of Kansas Medical Center
Kansas City, Kansas

Rajesh Pahwa, MD, has disclosed that he received: Consulting fees from Abbott, AbbVie, Acadia, Acorda, Adamas, Cala Health, Global Kinetics, Lundbeck, Neurocrine, Prilenia Therapeutics, PhotoPharmics, Sunovion, Teva Neuroscience, US WorldMeds; Grant/research support from Abbott, AbbVie, Acorda, Biogen, Boston Scientific, Cala Health, Cavion, Cynapsus, Intec Pharma, Jazz Pharmaceuticals, Kyowa Kirin, Eli Lilly and Company, National Institute of Neurological Disorders and Stroke/National Institutes of Health, National Parkinson Foundation, Parkinson Study Group, Roche, Sunovion, Theranexus, Theravance, US WorldMeds, Voyager.

Instructions for Credit

Accreditation

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

The University of Cincinnati designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve the competence of learners in considering current clinical approaches to address motor fluctuations and OFF time in patients with Parkinson disease.